Most Read News

Veranda Learning Solutions Limited has informed the Exchange about Submission of Monitoring Agency Report for the Quarter Ended September 30, 2022

The Exchange had sought clarification from PTC India Financial Services Limited with respect to announcement dated 09-Nov-2022 informing about Forensic Audit Report.On the basis of aforesaid disclosure, the Company was required to provide/clarify the following:(a) It is observed that the Forensic Audit report submitted by the Company is not legible and searchable. Accordingly, Company is requested to resubmit the Forensic Audit Report in machine readable and searchable form under the appropriate head. (b) Company shall disclose the below as a separate announcement:1. PFS Management Response 2. Remarks issued by Ernst &Young LLP (independent advisors to the management in relation to the forensic audit)The response of the company is attached.

Marksans Pharma Limited has informed the Exchange about appointment of JVJ & Co., Chartered Accountants firm as Internal Auditor of the company w.e.f. 14-Nov-2022

Ritco Logistics Limited has informed the Exchange about press release dated 15-Nov-2022 titled Press Release

The Exchange had sought clarification from Honeywell Automation India Limited with respect to announcement dated 08-11-2022 regarding Outcome of Board Meeting.On the basis of aforesaid disclosure, the Listed entity was required to clarify the following:1. Brief profile (in case of appointment)The response of the company is attached.

Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about appointment of PAVAN SINGH RAJPUT as Chief Financial Officer of the company w.e.f. 14-Nov-2022

Cinevista Limited has informed the Exchange about resignation of Niranjan Shivdasani as Independent Director of the company w.e.f. 14-Nov-2022

Birla Tyres Limited has informed the Exchange about Board Meeting held on 14-Nov-2022 to consider financial statements for the period ended September 2022.

Sub: Earnings Presentation on Q2 & H1 FY2023Pursuant to the SEBI (listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached a copy of the presentation on the financials for the quarter and half year ended September 30, 2022.

The Exchange had sought clarification from Aurobindo Pharma Limited with respect to announcement dated 10-Nov-2022 informing about arrest of Mr. P. Sarath Chandra Reddy, Whole Time Director / Promoter Group of the Company.On the basis of aforesaid disclosure, the Listed entity was required to clarify the following:1. Whether such fraud/default/arrest has been reported to appropriate authorities.2. Nature of fraud/default/arrest;3. Estimated impact on the listed entity;4. Time of occurrence;5. Person(s) involved;6. Estimated amount involved (if any);The response of the company is attached.